163 related articles for article (PubMed ID: 9458350)
21. [The relationship between multi-drug resistance gene expression and drug resistance of ovarian carcinoma].
Zhu L; Lang J; Shen K
Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):462-6. PubMed ID: 9639738
[TBL] [Abstract][Full Text] [Related]
22. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.
Li B; Ye T; Zhao L; Li DH; Gou XH; Zhao LY; Han L; Chen L; Yan LN; Gong JP
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):552-9. PubMed ID: 17085341
[TBL] [Abstract][Full Text] [Related]
23. MDR1 gene expression in primary and advanced breast cancer.
Yang X; Uziely B; Groshen S; Lukas J; Israel V; Russell C; Dunnington G; Formenti S; Muggia F; Press MF
Lab Invest; 1999 Mar; 79(3):271-80. PubMed ID: 10092063
[TBL] [Abstract][Full Text] [Related]
24. Chemoprotection effect of retroviral vector encoding multidrug resistance 1 gene to allow intensified chemotherapy in vivo.
Guo CB; Li YC; Jin XQ
Cancer Chemother Pharmacol; 2006 Jul; 58(1):40-9. PubMed ID: 16284790
[TBL] [Abstract][Full Text] [Related]
25. Osteoblastic differentiation and P-glycoprotein multidrug resistance in a murine osteosarcoma model.
Takeshita H; Kusuzaki K; Murata H; Suginoshita T; Hirata M; Hashiguchi S; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
Br J Cancer; 2000 Apr; 82(7):1327-31. PubMed ID: 10755409
[TBL] [Abstract][Full Text] [Related]
26. Effects of P-glycoprotein modulation on the chemotherapy of xenotransplanted human hepatoblastoma.
Warmann SW; Heitmann H; Teichmann B; Gratz KF; Ruck P; Hunger M; Fuchs J
Pediatr Hematol Oncol; 2005; 22(5):373-86. PubMed ID: 16020127
[TBL] [Abstract][Full Text] [Related]
27. Reversion effects of curcumin on multidrug resistance of MNNG/HOS human osteosarcoma cells in vitro and in vivo through regulation of P-glycoprotein.
Si M; Zhao J; Li X; Tian JG; Li YG; Li JM
Chin Med J (Engl); 2013 Nov; 126(21):4116-23. PubMed ID: 24229684
[TBL] [Abstract][Full Text] [Related]
28. ABCB1-overexpressing MG63/DOX cell xenograft model: maintain the MDR phenotype in vivo.
Zhou Z; Wan L; Han Y; Meng X; Yang Q; Li Y; Yu Q; Shen Z; Guo C
Pharm Biol; 2013 Aug; 51(8):968-73. PubMed ID: 23735077
[TBL] [Abstract][Full Text] [Related]
29. The role of c-myc in regulating mdr1 gene expression in tumor cell line KB.
He Y; Zhang J; Zhang J; Yuan Y
Chin Med J (Engl); 2000 Sep; 113(9):848-51. PubMed ID: 11776085
[TBL] [Abstract][Full Text] [Related]
30. Expression of the MRP and MDR1 multidrug resistance genes in small cell lung cancer.
Campling BG; Young LC; Baer KA; Lam YM; Deeley RG; Cole SP; Gerlach JH
Clin Cancer Res; 1997 Jan; 3(1):115-22. PubMed ID: 9815546
[TBL] [Abstract][Full Text] [Related]
31. Human multi-drug resistant hepatocellular carcinoma induced in nude mice by B-ultrasonographically-directed orthotopic implantation: a new experimental model.
Ding L; Chen XP; Zhang ZW; Jing K; Zhang WG
Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):393-8. PubMed ID: 17690036
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of gene MDR1 by shRNA to reverse multidrug-resistance of ovarian cancer A2780 cells.
Zhang H; Wang J; Cai K; Jiang L; Zhou D; Yang C; Chen J; Chen D; Dou J
J Cancer Res Ther; 2012; 8(2):226-31. PubMed ID: 22842366
[TBL] [Abstract][Full Text] [Related]
33. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
[TBL] [Abstract][Full Text] [Related]
34. [Expression of MDR1 and GST-pi in osteosarcoma and soft tissue sarcoma and their correlation with chemotherapy resistance].
Wei L; Song XR; Wang XW; Li M; Z uo WS
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):445-8. PubMed ID: 17152492
[TBL] [Abstract][Full Text] [Related]
35. Overcoming multidrug resistance in human carcinoma cells by an antisense oligodeoxynucleotide--doxorubicin conjugate in vitro and in vivo.
Ren Y; Wang Y; Zhang Y; Wei D
Mol Pharm; 2008; 5(4):579-87. PubMed ID: 18461970
[TBL] [Abstract][Full Text] [Related]
36. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
Wang TX; Yang XH
Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
[TBL] [Abstract][Full Text] [Related]
37. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W
J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
[TBL] [Abstract][Full Text] [Related]
38. HMN-176, an active metabolite of the synthetic antitumor agent HMN-214, restores chemosensitivity to multidrug-resistant cells by targeting the transcription factor NF-Y.
Tanaka H; Ohshima N; Ikenoya M; Komori K; Katoh F; Hidaka H
Cancer Res; 2003 Oct; 63(20):6942-7. PubMed ID: 14583495
[TBL] [Abstract][Full Text] [Related]
39. Multidrug resistance-1 gene expression does not increase during tumor progression in the MGH-OGS murine osteosarcoma tumor model.
Trammell RA; Johnson CB; Barker JR; Bell RS; Allan DG
J Orthop Res; 2000 May; 18(3):449-55. PubMed ID: 10937633
[TBL] [Abstract][Full Text] [Related]
40. Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance.
Fu L; Liang Y; Deng L; Ding Y; Chen L; Ye Y; Yang X; Pan Q
Cancer Chemother Pharmacol; 2004 Apr; 53(4):349-56. PubMed ID: 14666379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
